OCUL
NASDAQ · Pharmaceuticals
Ocular Therapeutix Inc
$9.43
-0.21 (-2.18%)
Open$10.00
Previous Close$9.64
Day High$10.39
Day Low$9.37
52W High$16.44
52W Low$6.23
Volume—
Avg Volume3.17M
Market Cap2.06B
P/E Ratio—
EPS$-1.46
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+501.3% upside
Current
$9.43
$9.43
Target
$56.70
$56.70
$44.23
$56.70 avg
$95.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 59.44M | 59.26M | 384.00M |
| Net Income | -304,214,720 | -272,974,325 | 56.73M |
| Profit Margin | -511.9% | -486.3% | 14.8% |
| EBITDA | -303,936,272 | -287,875,830 | 95.97M |
| Free Cash Flow | — | — | 61.23M |
| Rev Growth | +0.3% | +0.3% | -3.5% |
| Debt/Equity | 0.11 | 0.11 | 0.35 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,114.20 | +0.64% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $240.15 | +0.45% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $121.17 | +1.31% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.09 | -2.55% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.15 | +1.70% | 12.5 | 33.00B |